GEP data from BCWM.1 cells treated with LNA antimiR-155 or scramble control
Ontology highlight
ABSTRACT: microRNA-155 acts as an oncogenic miRNA in B-cell lymphoproliferative disorders including Waldenstrom Macroglobulinemia (WM) and Chronic Lymphocytic Leukemia (CLL). we used an 8-mer LNA (locked nucleic acid) phosphorothioate oligonucleotide targeting the seed region of miR-155 to effectively antagonize in vitro tumor growth in WM. We performed gene expression profiling (GEP) analysis on BCWM.1 cells after treatment with LNA antimiR-155 or scramble control for 48 hours.
ORGANISM(S): Homo sapiens
SUBMITTER: Yong Zhang
PROVIDER: E-GEOD-39189 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA